Brian Palumbo, MD
Orthopaedic Surgery · Temple Terrace, FLNPI 1770784324
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $322,295 of the $414,110 with a category attached, or 77.8%. Encore Medical, LP accounts for 85.8% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $134,343, 6.0 times the $22,447 reported in 2019. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $888.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$355K
- Conformis, Inc.$28K
- Restor3d, Inc.$18K
- Insight Medical Systems, Inc.$4K
- Zimmer Biomet$3K
- Stryker$679
- plus $4K from 35 others
Across 13 payments — averaging $1955.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$25K
What the payments were for
- Royalty or licence$25,1786%
- Consulting fees$322,29578%
- Speaking & faculty fees$13,8793%
- Travel & lodging$41,30010%
- Food & beverage$11,2963%
- Education$470%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 213 | $355,381 |
| Conformis, Inc. | 92 | $28,476 |
| Restor3d, Inc. | 24 | $17,897 |
| Insight Medical Systems, Inc. | 14 | $4,384 |
| Zimmer Biomet | 33 | $3,212 |
| Stryker | 11 | $679 |
| Innovation Technologies Inc | 4 | $495 |
| Maxx Orthopedics, Inc. | 4 | $333 |
| Smith+Nephew | 7 | $297 |
| Johnson & Johnson(2 entities) | 7 | $297 |
| Linkbio Corp | 2 | $274 |
| Heron Therapeutics, Inc. | 2 | $243 |
| Biocomposites Inc | 4 | $202 |
| Pacira Therapeutics, Inc. | 8 | $195 |
| Sanara Medtech Inc. | 1 | $181 |
| Solventum Corporation | 3 | $156 |
| Peter Brasseler Holdings, LLC | 1 | $128 |
| Think Surgical, Inc. | 3 | $123 |
| Engage Uni, LLC | 1 | $114 |
| Omnilife Science, Inc | 2 | $109 |
| Next Science LLC | 1 | $103 |
| Medacta USA, Inc. | 1 | $102 |
| KCI USA, Inc. | 2 | $98 |
| Lima USA, Inc. | 1 | $84 |
| Convatec Inc. | 3 | $80 |
| Vertex | 2 | $53 |
| Medtronic | 2 | $45 |
| Conmed Corporation | 1 | $44 |
| Curonix LLC | 2 | $42 |
| Polynovo North America LLC | 1 | $37 |
| Pacira Pharmaceuticals Incorporated | 2 | $37 |
| Coastal Medical Technologies LLC | 1 | $30 |
| Davol Inc. | 2 | $30 |
| ETS Wound Care LLC | 1 | $30 |
| Organogenesis Inc. | 1 | $21 |
| MVP Orthopedics Inc | 1 | $21 |
| Acera Surgical, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $16 |
| ERMI LLC | 1 | $14 |
| Heraeus Medical, LLC. | 2 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$392,963
- DJO Surgical TaperFill Hip System$18,816
- DJO Surgical Empowr Knee System$15,415
- Identity Imprint Knee Replacement System$7,076
- DJO Surgical FMP Acetabular System$6,625
- Pressfit$4,733
- iTotal Identity Cruciate Retaining Knee Replacement System$4,200
- ARVIS$4,191
- iTotal Identity PS$3,770
- Hip$1,930
- Hip, Identity$1,437
- Porous$1,286
- Oxford$1,269
- iTotal, Identity CR$1,200
- iTotal CR, iTotal PS, iUni, Hip System$915
- Identity Imprint CR$583
- Identity Imprint PS$583
- DJO Surgical 3DKnee System$527
- Irrisept$446
- mymobility Platform$374
How this compares
$414,110 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 34 | $733 |
| Meloxicam | 154 | $505 |
| Methylprednisolone | 66 | $413 |
| Amoxicillin | 55 | $77 |
| Clindamycin Hcl | 22 | $24 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Temple Terrace
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- Thomas BernasekTemple Terrace$6.4M
- Kenneth GustkeTemple Terrace$5.2M
- Mark MighellTemple Terrace$4.3M
- Michael GarciaTemple Terrace$1.1M
- Christopher BakerTemple Terrace$575K
- John SmallTemple Terrace$467K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.